Search Results Search Sort by RelevanceMost Recent Policy Forum Jun 2019 Mayo Clinic’s 5-Step Policy for Responding to Bias Incidents Rahma M. Warsame, MD and Sharonne N. Hayes, MD Patient bias towards clinicians and employees in health care is common, but policy to address bias and support staff is relatively limited. AMA J Ethics. 2019;21(6):E521-529. doi: 10.1001/amajethics.2019.521. Policy Forum May 2022 What Should Dietary Supplement Oversight Look Like in the US? Elizabeth Richardson, MSc, Farzana Akkas, MSc, and Amy B. Cadwallader, PhD Statutory limitations prevent the FDA from effectively regulating dietary supplements and have generated numerous calls for reform. AMA J Ethics. 2022;24(5):E402-409. doi: 10.1001/amajethics.2022.402. Policy Forum May 2022 Which Features of Dietary Supplement Industry, Product Trends, and Regulation Deserve Physicians’ Attention? Amy B. Cadwallader, PhD and AMA Council on Science and Public Health Illegal, fraudulent, adulterated, or improperly labeled products should be regarded as sources of possible clinical and ethical harm to patients. AMA J Ethics. 2022;24(5):E410-418. doi: 10.1001/amajethics.2022.410. Policy Forum Apr 2003 A Responsible Patient Swathi Arekapudi Virtual Mentor. 2003;5(4):144-146. doi: 10.1001/virtualmentor.2003.5.4.pfor1-0304. Policy Forum Apr 2017 Roles of Physicians and Health Care Systems in “Difficult” Clinical Encounters Elizabeth S. Goldsmith, MD, MS and Erin E. Krebs, MD, MPH Physicians’ perceptions of “difficult” encounters are related to perceived workload, job satisfaction, and communication training, similar to burnout. AMA J Ethics. 2017;19(4):381-390. doi: 10.1001/journalofethics.2017.19.4.pfor1-1704.
Policy Forum Jun 2019 Mayo Clinic’s 5-Step Policy for Responding to Bias Incidents Rahma M. Warsame, MD and Sharonne N. Hayes, MD Patient bias towards clinicians and employees in health care is common, but policy to address bias and support staff is relatively limited. AMA J Ethics. 2019;21(6):E521-529. doi: 10.1001/amajethics.2019.521.
Policy Forum May 2022 What Should Dietary Supplement Oversight Look Like in the US? Elizabeth Richardson, MSc, Farzana Akkas, MSc, and Amy B. Cadwallader, PhD Statutory limitations prevent the FDA from effectively regulating dietary supplements and have generated numerous calls for reform. AMA J Ethics. 2022;24(5):E402-409. doi: 10.1001/amajethics.2022.402.
Policy Forum May 2022 Which Features of Dietary Supplement Industry, Product Trends, and Regulation Deserve Physicians’ Attention? Amy B. Cadwallader, PhD and AMA Council on Science and Public Health Illegal, fraudulent, adulterated, or improperly labeled products should be regarded as sources of possible clinical and ethical harm to patients. AMA J Ethics. 2022;24(5):E410-418. doi: 10.1001/amajethics.2022.410.
Policy Forum Apr 2003 A Responsible Patient Swathi Arekapudi Virtual Mentor. 2003;5(4):144-146. doi: 10.1001/virtualmentor.2003.5.4.pfor1-0304.
Policy Forum Apr 2017 Roles of Physicians and Health Care Systems in “Difficult” Clinical Encounters Elizabeth S. Goldsmith, MD, MS and Erin E. Krebs, MD, MPH Physicians’ perceptions of “difficult” encounters are related to perceived workload, job satisfaction, and communication training, similar to burnout. AMA J Ethics. 2017;19(4):381-390. doi: 10.1001/journalofethics.2017.19.4.pfor1-1704.